Therapeutic efficacy and safety of Compound Kushen Injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An update systematic review and meta-analysis

• Main Authors: Xiao eMa (Author), Ruisheng eLi (Author), Jian eWang (Author), Yinqiu eHuang (Author), Pengyan eLi (Author), Ji eWang (Author), Haibin eSu (Author), Ruilin eWang (Author), Yaming eZhang (Author), Honghong eLiu (Author), Congen eZhang (Author), Zhijie eMa (Author), Jiabo eWang (Author), Yanling eZhao (Author), Xiaohe eXiao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2016-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Compound Kushen Injection (CKI) is a Chinese patent medicine approved by the Chinese State Food and Drug Administration for the treatment of various types of solid tumors. CKI, combined with transarterial chemoembolization (TACE), is believed to increase the therapeutic efficacy of unres...